Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:46 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1033–1056 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Critical Limb Ischemia
Interventions: Oxygenesys(TM) Dissolved Oxygen Dressing; Device
Lead sponsor: Halyard Health; Industry
Eligibility: 21 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Atrophy of Vagina, Vaginal Ulceration, Vaginitis
Interventions: Estradiol, placebo; Drug · Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Great Neck, New York

Conditions: Pressure Ulcer, Venous Ulcer, Diabetic Ulcer, Surgical Wound, Trauma Wound
Interventions: PuraPly™ Antimicrobial Wound Matrix; Device
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Ulcerative Colitis
Interventions: 5 ASA, enemas, suppositories, corticosteroids; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 66
States / cities: Birmingham, Alabama • Mobile, Alabama • Little Rock, Arkansas + 57 more

Conditions: Diabetic Foot Ulcers
Interventions: Not listed
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Healthy Participants
Interventions: Brazikumab; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Glendale, California

Conditions: Lower Extremity Chronic Ulcers in Diabetics
Interventions: CureXcell®, Sham injection; Biological
Lead sponsor: Macrocure Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 285 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 31
States / cities: Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 28 more

Conditions: Inflammatory Bowel Diseases
Interventions: Infliximab; Drug
Lead sponsor: Janssen Scientific Affairs, LLC; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 29
States / cities: Phoenix, Arizona • Los Angeles, California • San Francisco, California + 26 more

Conditions: Pressure Sore
Interventions: V.A.C.Ulta™ Negative Pressure Wound Therapy System, Standard of Care (Wet-to-dry dressings); Device · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Ulcerative Colitis
Interventions: MMX Mesalamine/Mesalazine (Low Dose), MMX Mesalamine/Mesalazine (High Dose); Drug
Lead sponsor: Shire; Industry
Eligibility: 5 Years to 17 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 9
States / cities: Baltimore, Maryland • Boston, Massachusetts • Newton, Massachusetts + 5 more

Conditions: Autoimmune Connective Tissue Disorder, Immune System Diseases
Interventions: Anakinra; Drug
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Achlorhydria, Gastrinoma, Zollinger Ellison Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1989 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Colitis, Ulcerative, Crohn's Disease
Interventions: Nutrition support product; Other
Lead sponsor: National University of Natural Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Active Ulcerative Colitis
Interventions: Afimkibart, Caffeine, Warfarin, Omeprazole, Dextromethorphan, Midazolam, Vitamin K; Drug · Other
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Chula Vista, California • Miami, Florida

Conditions: Diabetic Foot Ulcers
Interventions: ofloxacin, MSI-78; Drug
Lead sponsor: Abeona Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 342 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 1996
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Zollinger-Ellison Syndrome
Interventions: Esomeprazole magnesium (Nexium); Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 5
States / cities: Los Angeles, California • Gainesville, Florida • Columbus, Ohio + 2 more

Conditions: Diabetic Foot Ulcers, Wound Care
Interventions: AmnioClear™ Human Allograft Amniotic Membrane; Biological
Lead sponsor: Liventa Bioscience; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Diverticulum, Colon, Colorectal Neoplasms, Crohn Disease, Colitis, Ulcerative, Colostomy, Ileostomy - Stoma, Rectal Prolapse, Intestinal Polyposis, Lymphoma, Endometriosis, Intestinal Volvulus
Interventions: ColonRing™; Device
Lead sponsor: novoGI; Industry
Eligibility: 18 Years and older
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Riverdale, Georgia

Conditions: DFU, VLU, Surgical Wound, Wounds, Pressure Injuries
Interventions: cureVision cV; Diagnostic Test
Lead sponsor: Capsicure, LLC; Network
Eligibility: 22 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 5
States / cities: San Diego, California • Coral Gables, Florida • Miami, Florida + 1 more

Conditions: Ulcerative Colitis
Interventions: SAR339658; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 5
States / cities: Mission Hills, California • Miramar, Florida • Winter Park, Florida + 2 more

Conditions: Ulcerative Colitis
Interventions: UCRI; Diagnostic Test
Lead sponsor: Glycominds, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Diabetic Foot Ulcer
Interventions: Tissue Engineered Skin Substitute, Offloading, Amnionic Membrane Graft; Procedure · Device
Lead sponsor: Professional Education and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Martinsville, Virginia • Roanoke, Virginia

Conditions: Diabetic Foot Ulcer
Interventions: CDO electrochemical tissue oxygenation system, Moist Wound Therapy; Device
Lead sponsor: Electrochemical Oxygen Concepts, Inc.; Industry
Eligibility: 30 Years to 90 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 33
States / cities: Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 25 more

Conditions: Inflammatory Bowel Diseases, Irritable Bowel Syndrome, Ulcerative Colitis, Crohn Disease, Indeterminate Colitis, Chronic Diarrhea, Celiac Disease, Diverticulitis, Abdominal Pain, Distension, Weight Loss, Food Intolerance, Constipation
Interventions: Stool collection; Diagnostic Test
Lead sponsor: DiaSorin Inc.; Industry
Eligibility: 4 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 13
States / cities: Dothan, Alabama • Little Rock, Arkansas • Mission Hills, California + 10 more

Search by objective public record fields.

Dissolved Oxygen Dressing to Improve Chronic Wound Healing After Revascularization for Critical Limb Ischemia

Vaginal Creams to Reduce Vaginal Erosion in Pessary Users

PuraPly™ Antimicrobial Wound Matrix and Wound Management

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

WEMR With Clinical Decision Support for Diabetic Foot Ulcers

Study to Evaluate the Pharmacokinetics (Movement of Drugs Within the Body), Safety and Tolerability of Brazikumab in Healthy Chinese and White Participants

Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes

An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease

NPWTi on Closure of Chronic Pressure Sores

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

Anakinra for Behcet s Disease

Evaluating Patients With Abnormal Levels of Gastric Acid

Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease

An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds

Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

BIO-SEE: Bioburden Imaging Outcome Study for Equivalence Evaluation

Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)

Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.

Prospective, Comparitive, Randomized Study of Allograft Versus Skin Substitute in Non-healing Diabetic Foot Ulcers

A Prospective, Randomized, Double-Blind Multicenter Study Comparing CDO Therapy to Standard MWT in the Treatment of DFUs

Fecal Calprotectin Collection Protocol